secwatch.observer — SEC 8-K summary
======================================

Issuer:     Senti Biosciences, Inc. (SNTI)
CIK:        0001854270
Form:       8-K
Filed at:   2024-09-27T23:59:59+00:00
Accession:  0001854270-24-000105
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Senti subleases 7,247 RSF of HQ to BKPBIOTECH/JLSA2 Therapeutics
----------------------------------------------------------------

- Sublease of 7,247 rentable sq ft on first floor at Two Corporate Drive, South San Francisco.
- Term effective October 1, 2024 through April 30, 2027, subject to landlord consent.
- Initial monthly base rent $35,147.95, escalating to $36,378.13 (Y2) and $37,651.36 (Y3).
- Subtenant is jointly and severally BKPBIOTECH, Inc. and JLSA2 Therapeutics, Inc.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1854270/000185427024000105/0001854270-24-000105-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1854270/000185427024000105/snti-20240923.htm
  HTML page:      https://secwatch.observer/filing/0001854270-24-000105

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer